| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,434 |
970 |
$104K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,433 |
1,322 |
$46K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,613 |
1,093 |
$34K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,174 |
1,056 |
$26K |
| 80434 |
|
15 |
13 |
$98.26 |
| 86905 |
|
14 |
14 |
$30.64 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
29 |
29 |
$0.00 |
| 87088 |
|
29 |
29 |
$0.00 |
| 80155 |
|
15 |
15 |
$0.00 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
75 |
75 |
$0.00 |
| 87186 |
|
29 |
29 |
$0.00 |
| 83020 |
|
14 |
13 |
$0.00 |